Escherichia fergusonii Promotes Nonobese Nonalcoholic Fatty Liver Disease by Interfering With Host Hepatic Lipid Metabolism Through Its Own msRNA 23487
Feng‐Zhi Xin(Shanghai Jiao Tong University), Jian‐Gao Fan(XinHua Hospital), Rui-Nan Zhang(Shanghai Jiao Tong University), Chao Sun(Xi'an Medical University), Zizhen Gong(XinHua Hospital), Qianren Zhang(Shanghai Jiao Tong University), Lin Ye(Beijing Institute of Technology), Zixuan Wang(Shanghai Jiao Tong University), Xiaolin Liu(The Fifth People’s Hospital of Suzhou), Mengyu Wang(Zhengzhou University), Lin Zeng, Zehua Zhao(Capital University), Lei‐Jie Huang(Shanghai Jiao Tong University), Qin Pan(XinHua Hospital), Feng Shen(Shanghai Jiao Tong University), Lu Jiang(Tianjin Medical University)
Cited by 71
Related Papers
Identification of antimicrobial peptides from the human gut microbiome using deep learning
|Nature Biotechnology|2022|470
Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats
|Experimental & Molecular Medicine|2019|337
An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
|Nature Communications|2020|247
Sodium butyrate reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression
|Experimental & Molecular Medicine|2018|212